XML 36 R20.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Accounting Policies [Abstract] |
SCHEDULE OF RESTATEMENT OF CONSOLIDATED BALANCE SHEETS | The following tables present the effects of the Restatement on the Company’s consolidated balance sheets as of December 31, 2023 and 2022: SCHEDULE OF RESTATEMENT OF CONSOLIDATED BALANCE SHEETS
|  | As Previously |  |  | Restatement |  |  | As |
|  | December 31, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | - |  |  | $ | 1,543,953 |  |  | $ | 1,543,953 |
Total current liabilities |  | $ | 1,063,392 |  |  | $ | 1,543,953 |  |  | $ | 2,607,345 |
Total liabilities |  | $ | 1,063,392 |  |  | $ | 1,543,953 |  |  | $ | 2,607,345 |
Stockholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital |  | $ | 178,590,256 |  |  | $ | (21,901,000 | ) |  | $ | 156,689,256 |
Accumulated deficit |  | $ | (167,056,381 | ) |  | $ | 20,357,047 |  |  | $ | (146,699,334 | )
Total stockholders’ equity |  | $ | 11,548,328 |  |  | $ | (1,543,953 | ) |  | $ | 10,004,375 |
Total liabilities and stockholders’ equity |  | $ | 12,611,720 |  |  | $ | - |  |  | $ | 12,611,720 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | December 31, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |  |  |
Derivative liabilities |  | $ | - |  |  | $ | 5,541,733 |  |  | $ | 5,541,733 |
Total current liabilities |  | $ | 440,302 |  |  | $ | 5,541,733 |  |  | $ | 5,982,035 |
Total liabilities |  | $ | 602,619 |  |  | $ | 5,541,733 |  |  | $ | 6,144,352 |
Stockholders’ equity |  |  |  |  |  |  |  |  |  |  |  |
Additional paid-in capital |  | $ | 168,457,418 |  |  | $ | (21,901,000 | ) |  | $ | 146,556,418 |
Accumulated deficit |  | $ | (152,640,897 | ) |  | $ | 16,359,267 |  |  | $ | (136,281,630 | )
Total stockholders’ equity |  | $ | 15,832,072 |  |  | $ | (5,541,733 | ) |  | $ | 10,290,339 |
Total liabilities and stockholders’ equity |  | $ | 16,434,691 |  |  | $ | - |  |  | $ | 16,434,691 |
SCHEDULE OF RESTATEMENT OF CONSOLIDATED STATEMENTS OF OPERATIONS | The following tables present the effects of the Restatement on the Company’s consolidated statements of operations for the years ended December 31, 2023 and 2022: SCHEDULE OF RESTATEMENT OF CONSOLIDATED STATEMENTS OF OPERATIONS
|  | As Previously |  |  | Restatement |  |  | As |
|  | For the Year Ended |
|  | December 31, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
Change in fair value of derivative liabilities |  | $ | - |  |  | $ | (3,997,780 | ) |  | $ | (3,997,780 | )
Total other income |  | $ | (805,290 | ) |  | $ | (3,997,780 | ) |  | $ | (4,803,070 | )
Net (loss) income |  | $ | (14,415,484 | ) |  | $ | 3,997,780 |  |  | $ | (10,417,704 | )
Earnings (loss) per share - basic and diluted |  | $ | (3.42 | ) |  | $ | 0.95 |  |  | $ | (2.47 | )
|  | As Previously |  |  | Restatement |  |  | As |
|  | For the Year Ended |
|  | December 31, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
Change in fair value of derivative liabilities |  | $ | - |  |  | $ | (5,272,473 | ) |  | $ | (5,272,473 | )
Total other income |  | $ | (479,256 | ) |  | $ | (5,272,473 | ) |  | $ | (5,751,729 | )
Net (loss) income |  | $ | (18,494,769 | ) |  | $ | 5,272,473 |  |  | $ | (13,222,296 | )
Loss per share: |  |  |  |  |  |  |  |  |  |  |  |
Earnings (loss) per share - basic and diluted |  | $ | (5.11 | ) |  | $ | 1.46 |  |  | $ | (3.65 | )
SCHEDULE OF RESTATEMENT OF CONSOLIDATED STATEMENTS OF CHANGE IN STOCKHOLDERS’ EQUITY | The following tables present the effects of the Restatement on the Company’s consolidated statements of changes in stockholders’ equity for the years ended December 31, 2023 and 2022: SCHEDULE OF RESTATEMENT OF CONSOLIDATED STATEMENTS OF CHANGE IN STOCKHOLDERS’ EQUITY
Balance - December 31, 2023 (as previously reported) |  | $ | 178,590,256 |  |  | $ | (167,056,381 | ) |  | $ | 11,548,328 |
Adjustment due to cumulative error correction |  |  | (21,901,000 | ) |  |  | 16,359,267 |  |  |  | (5,541,733 | )
Change in fair value of derivative liability |  |  | - |  |  |  | 3,997,780 |  |  |  | 3,997,780 |
Balance - December 31, 2023 (as restated) |  | $ | 156,689,256 |  |  | $ | (146,699,334 | ) |  | $ | 10,004,375 |
Balance - December 31, 2022 (as previously reported) |  | $ | 168,457,418 |  |  | $ | (152,640,897 | ) |  | $ | 15,832,072 |
Adjustment due to cumulative error correction |  |  | (21,901,000 | ) |  |  | 11,086,794 |  |  |  | (10,814,206 | )
Change in fair value of derivative liability |  |  | - |  |  |  | 5,272,473 |  |  |  | 5,272,473 |
Balance - December 31, 2022 (as restated) |  | $ | 146,556,418 |  |  | $ | (136,281,630 | ) |  | $ | 10,290,339 |
SCHEDULE OF RESTATEMENT OF CONSOLIDATED STATEMENT OF CASH FLOWS | The following tables present the effects of the Restatement on the Company’s consolidated statements of cash flows for the years ended December 31, 2023 and 2022: SCHEDULE OF RESTATEMENT OF CONSOLIDATED STATEMENT OF CASH FLOWS
|  | As Previously |  |  | Restatement |  |  | As |
|  | December 31, 2023 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
Cash Flows From Operating Activities: |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) income |  | $ | (14,415,484 | ) |  | $ | 3,997,780 |  |  | $ | (10,417,704 | )
Adjustments to reconcile net (loss) income to net cash used in operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of derivative liability |  | $ | - |  |  | $ | (3,997,780 | ) |  | $ | (3,997,780 | )
Net Cash Used In Operating Activities |  | $ | (6,430,211 | ) |  | $ | - |  |  | $ | (6,430,211 | )
|  | As Previously |  |  | Restatement |  |  | As |
|  | December 31, 2022 |
|  | As Previously |  |  | Restatement |  |  | As |
|  | Stated |  |  | Adjustments |  |  | Restated |
Cash Flows From Operating Activities: |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) income |  | $ | (18,494,769 | ) |  | $ | 5,272,473 |  |  | $ | (13,222,296 | )
Adjustments to reconcile net (loss) income to net cash used in operating activities: |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of derivative liability |  | $ | - |  |  | $ | (5,272,473 | ) |  | $ | (5,272,473 | )
Net Cash Used In Operating Activities |  | $ | (5,913,100 | ) |  | $ | - |  |  | $ | (5,913,100 | )
SCHEDULE OF WEIGHTED AVERAGE DILUTIVE COMMON SHARES | The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive due to the Company’s net loss position even though the exercise price could be less than the average market price of the common shares: SCHEDULE OF WEIGHTED AVERAGE DILUTIVE COMMON SHARES
|  | For the Years Ended |
|  | December 31, |
|  | 2023 |  |  | 2022 |
Stock options |  |  | 1,466,892 |  |  |  | 864,639 |
Warrants |  |  | 4,791,019 |  |  |  | 4,791,082 |
Unvested RSUs |  |  | 97,827 |  |  |  | 201,870 |
Convertible Preferred Stock |  |  | 1,398,158 |  |  |  | 1,518,158 |
Total |  |  | 7,753,896 |  |  |  | 7,375,749 |

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph (a) -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph (a) -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph (a) -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration